Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver Journal Article


Authors: Wallace, M. D.; Pfefferle, A. D.; Shen, L.; McNairn, A. J.; Cerami, E. G.; Fallon, B. L.; Rinaldi, V. D.; Southard, T. L.; Perou, C. M.; Schimenti, J.
Article Title: Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver
Abstract: Identifying genomic alterations driving breast cancer is complicated by tumor diversity and genetic heterogeneity. Relevant mouse models are powerful for untangling this problem because such heterogeneity can be controlled. Inbred Chaos3 mice exhibit high levels of genomic instability leading to mammary tumors that have tumor gene expression profiles closely resembling mature human mammary luminal cell signatures. We genomically characterized mammary adenocarcinomas from these mice to identify cancer-causing genomic events that overlap common alterations in human breast cancer. Chaos3 tumors underwent recurrent copy number alterations (CNAs), particularly deletion of the RAS inhibitor Neurofibromin 1 (Nf1) in nearly all cases. These overlap with human CNAs including NF1, which is deleted or mutated in 27.7% of all breast carcinomas. Chaos3 mammary tumor cells exhibit RAS hyperactivation and increased sensitivity to RAS pathway inhibitors. These results indicate that spontaneous NF1 loss can drive breast cancer. This should be informative for treatment of the significant fraction of patients whose tumors bear NF1 mutations. © 2012 by the Genetics Society of America.
Journal Title: Genetics
Volume: 192
Issue: 2
ISSN: 0016-6731
Publisher: Genetics Society of America  
Date Published: 2012-10-01
Start Page: 385
End Page: 396
Language: English
DOI: 10.1534/genetics.112.142802
PROVIDER: scopus
PMCID: PMC3454871
PUBMED: 22851646
DOI/URL:
Notes: --- - "Export Date: 2 November 2012" - "CODEN: GENTA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ethan Cerami
    21 Cerami